SCD and hepatocellular carcinoma: Last, a recent study has shown that by activating the liver X receptor alpha (LXRa) and inhibiting the Raf-1-SCD1 protein complex in liver carcinomas, an intracellular accumulation of saturated free fatty acids occurs and leads to lethal lipotoxicity in these tumor cells.